Who Should Attend

  • Medical Professionals
  • Researchers
  • Clinicians
  • Clinical Professionals
  • Project Managers
  • Notified Bodies
  • Regulatory Affairs Specialists
  • R&D Personnel
  • Professionals in the field of Orphan Drugs
  • CEOs
  • CROs / CRAs
  • Pharmaceutical Company Representatives
  • Start-up Companies
  • Industry professionals